Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Drug type-
AI-Powered Drug Discovery in Dermatology in Healthcare Market Advancement Enabled by Integration of Natural Language Processing and Generative Models
InsightAce Analytic Pvt. Ltd.
Mitochondrial-Based Therapeutics Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd.
Diabetic Macular Edema Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd.
Pharmaceutical REMS Market Demand Shaped by Specialty Drugs and Chronic Disease Treatments
InsightAce Analytic Pvt. Ltd.
Mitochondrial DNA Market Analysis on Technological Advancements in Genetic Testing Personalized Medicine and Cancer Genomics
InsightAce Analytic Pvt. Ltd.
PD-1 Inhibitor Drugs Market Trends and the Future of Cancer Immunotherapy
PD-1 Inhibitor Drugs Market Size, Share & Trends Analysis Report By Drug Type (Pembrolizumab, Nivolumab, Cemiplimab, Dostarlimab, Others), Indication (Melanoma, Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Kidney Cancer, Head And Neck Cancers, Stomach Cancer, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts 2025-2034 InsightAce Analytic Pvt. Ltd.
Mitochondrial-Based Therapeutics Market Exclusive Report with Detailed Study Analysis
Mitochondrial-Based Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication, By Route of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031 InsightAce Analytic Pvt. Ltd.
Diabetic Macular Edema Market Report Latest Trends and Future Opportunities Analysis In New Report
Diabetic Macular Edema Market Size, Share & Trends Analysis Report By Drug Type (Anti-VEGF (Ranibizumab (Lucentis), Aflibercept (Eylea)), Corticosteroid Therapies (Dexamethasone (Ozurdex), Fluocinolone Acetonide (Iluvien)), Others), By Form (Intravitreal Injections, Intravitreal Implants), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031 InsightAce Analytic Pvt. Ltd.
GERD Therapeutics Market Projected to Reach $6.06 Billion by 2031 with a CAGR of 1.58%
InsightAce Analytic projects that the Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market will grow to over USD 6.06 billion by 2031, with a CAGR of 1.58%. InsightAce Analytic Pvt. Ltd.
Orphan Drugs CDMO Market Set to Grow with a 10.9% CAGR by 2031
InsightAce Analytic Pvt. Ltd. forecasts that the global Orphan Drugs CDMO market will achieve a 10.9% CAGR and exceed $22 billion by 2031 InsightAce Analytic Pvt. Ltd.
Hypercholesterolemia Treatment Market Set to Surpass $36 Billion by 2031
The Hypercholesterolemia Treatment Market, valued at $27.9 billion in 2023, is expected to reach approximately $36.37 billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031, according to InsightAce Analytic's latest report. According to a new report by InsightAce Analytic, the "Hypercholesterolemia Treatment Market” in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $36.37 billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.
Orphan Drugs CDMO Market Europe Leading the Orphan Drug CDMO Market: A Comparative Analysis of Market Size, Regulatory Landscape, and Industry Ecosystem.
Orphan Drugs CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd.
Orphan Drugs CDMO Market to Experience Significant Growth with a 10.9% CAGR by 2031 As Revealed In New Report
As awareness and research into rare diseases expand, the demand for effective orphan drug therapies, particularly in oncology, is surging. This report by InsightAce Analytic provides an in-depth analysis of market trends, competitive dynamics, and future revenue forecasts, highlighting key players and regional developments driving this vital sector forward. InsightAce Analytic Pvt. Ltd.
PD-1 Inhibitors Market: Driving Innovation, Expanding Therapeutic Applications, and Improving Patient Survival Rates
PD-1 and PD-L1 Inhibitors Market to reach over USD XX billion by the year 2031 - Exclusive Report by InsightAce Analytic “PD-1 and PD-L1 Inhibitors Market” in terms of revenue was estimated to be worth $XX billion in 2023 and is poised to reach $XX billion by 2028, growing at a CAGR of XX% from 2024 to 2031 according to a new report by InsightAce Analytic.
Gastroesophageal Reflux Disease Therapeutics Market Heartburn Relief on the Rise: The Expanding Gastroesophageal Reflux Disease Therapeutics Market
Gastroesophageal Reflux Disease Therapeutics Market to reach over USD 6.06 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd.
Hypercholesterolemia Treatment Market Combating Cholesterol: The Rising Tide of the Hypercholesterolemia Treatment Market
Hypercholesterolemia Treatment Market to reach over USD 36.37 billion by the year 2031 - Exclusive Report by InsightAce Analytic According to a new report by InsightAce Analytic, the "Hypercholesterolemia Treatment Market” in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $36.37 billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.
Pharma Parenteral Packaging Market Safeguarding Sensitive Treatments: Growth in the Pharma Parenteral Packaging Market
Pharma Parenteral Packaging Market in the North America is Anticipated to Register a Significant Share in Revenue to 2031 – Here’s Why InsightAce Analytic Pvt. Ltd.
Eisenmenger Syndrome Treatment Market Future Growth and Leading Players
Eisenmenger Syndrome develops due to high blood pressure in the lungs, which is known as pulmonary hypertension. Pulmonary hypertension occurs due to certain congenital heart The latest intelligence report published by CMI with the title""Eisenmenger Syndrome Treatment Market - Growth Insights, Forecast to 2031" provides current updates and strategic steps taken by competition along with growth estimates of market size.
Pharma Parenteral Packaging Market 2024: Trends, Analysis, And Industry Insights
Pharma Parenteral Packaging Market 2024: Trends, Analysis, And Industry Insights 5/13/2024 3:06:42 PM (MENAFN- GetNews) "Pharma Parenteral Packaging Market"Pharma Parenteral Packaging Market is valued at US$ 13.28 Bn in 2023, and it is expected to reach US$ 18.85 Bn by 2031, with a CAGR of 4.47% during the forecast period of 2024-2031. InsightAce Analytic Pvt. Ltd.
Pharma Parenteral Packaging Market in the North America is Anticipated to Register a Significant Share in Revenue to 2031 - Exclusive Report by InsightAce Analytic
, /PRNewswire/ -- InsightAce Analytic Pvt. Ltd.
UK Biotech Database
Biotechgate Global Database › Global Trial › Global Log-in › Upcoming Life Sciences Events April 2024 London: BioTrinity 2024 Singapore: Asia Bio Partnering Forum London: LSX World Congress About Biotechgate The UK Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate.
Back Pain Therapy Market Growth, Dynamics, Segmentation, Scope, Trends, Segmentation,and Forecast.
Back pain is mainly caused due to muscular strains, strained ligaments, and muscular spasms in any region of the back. Chronic diseases such as herniated discs, arthritis, and osteoporosis can lead to back pain. Coherent Market Insights introduces new research on the Back Pain Therapy Market covering the micro level of analysis by competitors and key business segments (2024-2031).
Orphan Drugs CDMO Market Latest Trends and Future Aspect Analysis In The Latest Research
Orphan Drugs CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd.
Hypercholesterolemia Treatment Market 2024: Trends, Therapies, and Growth Analysis
Hypercholesterolemia Treatment Market 2024: Trends, Therapies, and Growth Analysis Hypercholesterolemia Treatment Market According to a new report by InsightAce Analytic, the “Hypercholesterolemia Treatment Market” in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $36.37 billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.
Alleviating Discomfort: Investigating the Back Pain Therapy Market 2024 Size Status, Growth Strategies| Pfizer, Inc.
Back pain is mainly caused due to muscular strains, strained ligaments, and muscular spasms in any region of the back. BURLINGAME, CALIFORNIA , UNITED STATES, March 6, 2024 /EINPresswire.com/ -- The Latest Research Report on the Back Pain Therapy Market 2024 to 2031 delivers precise economic forecasts, global and country-level predictions, and comprehensive analyses.
Investigating the Back Pain Therapy Market 2024 Size Status, Growth Strategies| Pfizer, Inc.
BURLINGAME, CALIFORNIA , UNITED STATES, March 6, 2024 / EINPresswire.com/ -- The Latest Research Report on the Back Pain Therapy Market 2024 to 2031 delivers precise economic forecasts, global and country-level predictions, and comprehensive analyses. It offers a detailed perspective on the competitive landscape and conducts an in-depth supply chain analysis to aid businesses in identifying significant shifts in industry practices.
PARP Inhibitors Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitors Market Size, Share & Trends Analysis Report By Product (Niraparib (Zejula), Olaparib (Lynparza), Rucaparib (Rubraca), Talazoparib (Talzenna), Veliparib, Other Pipeline Drugs), By Indication (breast cancer, ovarian cancer, and prostate and pancreatic cancer), Region, Market Outlook And Industry Analysis 2031".
Back Pain Therapy Market Expected to Expand at a Steady 2024-2031
The "Back Pain Therapy Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031. Coherent Market Insights has released a statistical report titled "Back Pain Therapy Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data.
Gastroesophageal Reflux Disease Therapeutics Market Size, Share and Trends Analysis Report 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-kinetic agents)- Market Outlook And Industry Analysis 2031" The global Gastroesophageal Reflux Disease Therapeutics market is estimated to reach over USD 6.06 billion by 2031, exhibiting a CAGR of 1.58% during the forecast period.
PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd.
PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
, /PRNewswire/ -- InsightAce Analytic Pvt. Ltd.
Back Pain Therapy Market Exploring Innovations in Trends, Demand, and Forecasts to 2031 | Celebrex, H.J. Harkins Company
BURLINGAME, CALIFORNIA, UNITED STATES, February 8, 2024 /EINPresswire.com/ -- The "Back Pain Therapy Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031.
Back Pain Therapy Market Exploring Innovations in Trends, Demand, and Forecasts to 2031
BURLINGAME, CALIFORNIA, UNITED STATES, February 8, 2024 / EINPresswire.com/ -- The " Back Pain Therapy Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031.
Acute Invasive Aspergillosis Treatment Market Strategies and Innovations in to See Booming Growth 2024-2031
The "Acute Invasive Aspergillosis Treatment Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031.
Orphan Drugs CDMO Market Growth and Restrain Factors Analysis 2023-2031
InsightAce Analytic Pvt. Ltd.
[Newly launched] Orphan Drugs Market is estimated to be US$ Original
Covina , Sept. 12, 2023 (GLOBE NEWSWIRE) -- Introduction: Orphan drugs are used to treat and diagnose an orphan disease which can be serious or even cause life-threating. Orphan drugs are not developed in industry, but it is generated for the public welfare. An orphan drug may be a pharmaceutical agent developed to treat medical conditions which, because they're so rare, wouldn't be profitable to supply without government assistance.
Eisenmenger Syndrome Treatment Market Demands and Gross Margin 2030 | Actelion Pharmaceuticals Ltd., Gilead Sciences, Inc., Pfizer, Inc.
The exclusive research report on ‘Eisenmenger Syndrome Treatment Market‘ now available with Coherent Market Insights, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Eisenmenger Syndrome Treatment Market.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Drug
Contact Drug, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack